Table I Index
Table of Contents
|
Table I - 30 Hancock Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 212 | 384.6 | 99 | 401.8 | 113 | 372.7 |
| Oral cavity and pharynx | 6 | 11.3** | 5 | 21.3** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 31 | 55.0 | 16 | 64.3** | 15 | 46.1** |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 18 | 31.4** | 10 | 41.0** | 8 | 24.0** |
| Rectum and rectosigmoid | 6 | 11.0** | * | # | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | * | # | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 53 | 98.7 | 33 | 133.8 | 20 | 71.4 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 48 | 89.9 | 30 | 123.4 | 18 | 64.6** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 7 | 10.1** | * | # | 5 | 12.6** |
| Melanoma of the skin | 6 | 8.8** | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 35 | 59.4 | * | # | 35 | 115.7 |
| Female genital system | 8 | 14.6** | -- | -- | 8 | 28.5** |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | * | # | -- | -- | * | # |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | * | # | -- | -- | * | # |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 14 | 26.2** | 14 | 54.4** | -- | -- |
| Prostate gland | 12 | 23.6** | 12 | 48.9** | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 18 | 32.7** | 13 | 51.3** | 5 | 15.3** |
| Urinary bladder | 15 | 27.4** | 11 | 42.4** | * | # |
| Kidney and renal pelvis | * | # | * | # | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 5 | 10.8** | * | # | * | # |
| Brain | * | # | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 11 | 19.3** | * | # | 7 | 19.9** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 10 | 18.1** | * | # | 6 | 17.6** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 7 | 14.4** | 5 | 23.2** | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 7 | 11.6** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||